艾迪藥業(688488.SH):與中艾協就中國艾滋病防控事業達成初步合作意向
格隆匯1月24日丨艾迪藥業(688488.SH)公佈,公司近日與中國性病艾滋病防治協會(簡稱“中艾協”)經友好協商,達成戰略合作意向並簽訂了《戰略合作意向備忘錄》。
雙方從“滿足國內艾滋病治療的迫切需求”戰略出發,計劃開展面向中國艾滋病領域的多維度合作,聚焦患者治療與疾病管理、臨牀診療與科研能力建設以及社會公益項目等,雙方將發揮各自在模式探索、學術交流、能力建設等領域的專長,更好地助力中國艾滋病防控事業,並將在如下方面開展密切合作:
1、探索創新性艾滋病防治方案:通過開展艾滋病患者的流行病學和藥物經濟學研究,為優化艾滋病防治模式提供循證依據;
2、探索建立診療一體化管理模式:從艾滋病的檢測、診斷、治療、隨訪管理等多環節入手,推動艾滋病診療管理一體化;
3、加強艾滋病從業人員能力建設:從艾滋病防控醫務人員的實際需求出發,搭建學術交流平台,開展多種形式的能力建設活動和培訓。
艾迪藥業為支持中國艾滋病防控事業,意向性計劃在未來三年內投入人民幣3000萬元用於開展上述合作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.